

주문정보




- - 재고수량은 변동될 수 있습니다.
- - 재고 확인 시 "갱신" 버튼을 누르시면 실시간 재고를 확인하실 수 있습니다.
- - 가격이 ‘별도문의‘ 시, 상단 ‘견적신청’ 버튼을 눌러 문의해주시면 빠른 답변을 받으실 수 있습니다.
선택 | Cat.No. | 제품명 | 가격(VAT별도) | 수량 |
---|
제품특징
□ EF-1 Alpha Promoter Vectors
Human elongation factor-1 alpha (EF-1 alpha) is a constitutive promoter of human origin that can be used to drive ectopic gene expression in various in vitro and in vivo contexts (1). EF-1 alpha is often useful in conditions where other promoters (such as CMV) have diminished activity or have been silenced (as in embryonic stem cells; 2). EF-1 alpha promoter vectors are available in multiple formats for either plasmid or lentiviral delivery:
● Fluorescent protein fusion vectors
● IRES vectors for coexpression of 2 genes
● Vectors with highly immunoreactive Myc- or HA-tags that can be used to confirm Matchmaker interactions in
mammalian cells
Figure 1. EF-1 alpha expression vectors for many applications. Plasmid and lentiviral vector choices are available carrying the EF-1 alpha promoter. IRES: internal ribosome entry sequence; FP1: fluorescent protein (AcGFP1, DsRed-Monomer, or mCherry); FP2: fluorescent protein (mCherry or ZsGreen1); MCS: multiple cloning site
□ Storage Conditions
-20°C
□ References
1.Teschendorf, C., et al. (2002) Anticancer Res. 22(6A):3325-3330. 2.Kim S, et al. (2007) Stem Cells Dev. 16(4):537-45. 3.Wang, et al. (2008) Stem Cells Dev.17:279-289.